Clinical Trials Browser

Phase 3 × Glutamine × 1 year × Clear all

NCT05852990 2026-04-09

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07287592 2025-12-17

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

Phase 3 Not yet recruiting

Neoplasms